<DOC>
	<DOC>NCT00994942</DOC>
	<brief_summary>Determine the pharmacokinetics and optimize study design for subsequent studies with morphine sulfate tablets and solution.</brief_summary>
	<brief_title>Bioequivalency Study of Morphine Sulfate Injection, Solution and Tablet Under Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Morphine</mesh_term>
	<criteria>No clinically significant abnormal findings on the physical examination, medical history, or clinical laboratory results during screening. Positive test for HIV, Hepatitis B, or Hepatitis C. Treatment with known enzyme altering drugs. History of allergic or adverse response to morphine sulfate or any comparable or similar product.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>